Last reviewed · How we verify

NCT04536480

Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)

Recruiting now NA Last updated 24 June 2025
What this trial tests

NA trial testing Time Limited Eating in Pediatric Obesity in 100 participants. Currently enrolling.

Timeline
15 April 2023
Primary endpoint
1 December 2026
1 December 2027

Quick facts

Lead sponsorChildren's Hospital Los Angeles
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date15 April 2023
Primary completion1 December 2026
Estimated completion1 December 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital Los Angeles

Who can join

Adults 12 to 21, any sex, with Pediatric Obesity or Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To find the effectiveness of a diet plan (Time Limited Eating or TLE) on glycemic control, B-cell function, body fat, and body mass index (BMI) in adolescents with type 2 diabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Randomized Controlled Feasibility Trial of Late 8-Hour Time-Restricted Eating for Adolescents With Type 2 Diabetes.
    Hegedus E, Vu MH, Salvy SJ, Bakhsh J, et al · · 2024 · cited 13× · PMID 39464252 · DOI 10.1016/j.jand.2023.10.012

Verify or expand the search:

Other trials of Time Limited Eating

Trials testing the same drug.

Other recruiting trials for Pediatric Obesity

Currently open trials in the same condition.

Other Children's Hospital Los Angeles trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04536480.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing